Fundraising Fox

Paul Sekhri

Investor

Investor at eGenesis, Inc. Full-time

New York, New York

Writes $100K – $5M checks Β· typically $1.5M

About

Paul J. Sekhri is Chairman, President, and Chief Executive Officer of vTv Therapeutics, where he has overseen the company's restructuring and financing to advance a diabetes therapy into Phase III clinical trials. With nearly four decades of experience in pharmaceutical and biotechnology leadership, he has served as Director, Chairman, or Executive Chairman on more than 40 public and private company boards across the United States, Europe, and Israel, with expertise in board governance, capital formation, M&A, and business development. He holds degrees in Membrane Physiology and Zoology from the University of Maryland School of Medicine and is based across North America and Europe.

Experience

  1. vTv Therapeutics LLCChair, President and CEO, vTv Therapeutics, Inc.current2022 β€” presentNew York, New York, United States
  2. ApnimedChairperson of the Boardcurrent2026 β€” presentBoston, MA
  3. Oryn TherapeuticsExecutive Chaircurrent2026 β€” present
  4. Violet TherapeuticsExecutive Chaircurrent2024 β€” present
  5. Deep GenomicsMember Board of Directorscurrent2025 β€” present
  6. Resolution TherapeuticsChair of the Board of Directorscurrent2024 β€” presentLondon Area, United Kingdom
  7. KayotheraMember Board of Directorscurrent2024 β€” presentSeattle, Washington, United States
  8. LikeMindsMember Board of Directorscurrent2016 β€” present
  9. Veeva SystemsBoard Membercurrent2014 β€” presentSan Francisco Bay Area
  10. AdhereTechBoard Member2024 β€” 2025New Jersey, United States
  11. Compugen Ltd.Chair of the Board of Directors2017 β€” 2025Tel Aviv Area, Israel
  12. ORYN THERAPEUTICS, LLCBoard Member2022 β€” 2024San Diego Metropolitan Area
  13. Longboard PharmaceuticalsChair of the Board of Directors2021 β€” 2024San Diego, California, United States
  14. Spring DiscoveryBoard Member2021 β€” 2024San Diego, California, United States
  15. eGenesis, Inc.Board Member2019 β€” 2024Cambridge, Massachusetts, United States
  16. eGenesis, Inc.President and CEO2019 β€” 2022New York, New York
  17. IpsenBoard Director2018 β€” 2023Paris Area, France
  18. Pharming Group N.V.Chair of the Board of Directors2015 β€” 2023Amsterdam Area, Netherlands
  19. BiomX IncBoard Director2020 β€” 2022Tel Aviv, Israel
  20. Alpine Immune Sciences, Inc.Board Director2017 β€” 2020Greater Seattle Area

Education

  1. University of Maryland School of MedicineNeuroscience1982 β€” 1985
  2. University of MarylandB.Sc., Zoology1978 β€” 1981
  3. Allegheny CollegeBiology, General1976 β€” 1978
  4. University of MarylandBachelor's degree, Zoology/Animal Biology1979 β€” 1982

Skills & more

Board LeadershipVenture Capital41Pharmaceuticals3Biotechnology99Business Development36Licensing14Pharmaceutical Industry99Technology Transfer67Sop1Biomarkers3Lifesciences37Clinical Trials22
+12 moreCorporate DevelopmentMedical DevicesClinical DevelopmentProduct LaunchNeurologyMarket AccessStrategic PlanningOncologyValidationProduct DevelopmentStrategyCTMS

Languages French

From Paul's professional profile.

Colleagues at eGenesis, Inc. Full-time

Frequently asked questions

Where does Paul Sekhri work?
Paul Sekhri is at eGenesis, Inc. Full-time.
What check size does Paul Sekhri write?
Paul Sekhri typically writes checks of $100K – $5M.

Founder mafias

Same school

Shared employers